Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Pain, Analgesia, Pregnancy

In brief

This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated with the Neurocuple device will experience less pain and consequently require less opioid pain medication after cesarean delivery compared to women who receive standard post-surgical medication.

Key facts

Study ID
NCT07185425
Run by
Inova Health Care Services
People needed
180
Starts
2025-10-13
Expected to finish
2027-09-01
Last updated by the study team
2025-10-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.